Bioventus Inc.BVSNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank69
5Y CAGR-1.2%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-1.2%/yr
Long-term compound
Percentile
P69
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202513.88%
Q3 2025-6.10%
Q2 202519.20%
Q1 2025-19.37%
Q4 202410.56%
Q3 2024-8.10%
Q2 202416.81%
Q1 2024-4.41%
Q4 202312.11%
Q3 2023-11.87%
Q3 202315.13%
Q2 2023-5.38%
Q4 2022-2.20%
Q4 2022-8.32%
Q3 202219.64%
Q2 2022-10.06%
Q4 202119.77%
Q4 2021-0.84%
Q3 202134.29%
Q2 2021-17.05%
Q4 202014.76%
Q3 202048.07%
Q2 2020-26.23%
Q1 2020-19.38%
Q4 201918.62%
Q3 20192.58%
Q2 20190.00%
Q1 20190.00%
Q1 20160.00%
Q1 20150.00%